+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts



Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts



Clinical Kidney Journal 8(6): 722-728



Glomerulopathy due to dysproteinemia can have a wide spectrum of pathologic and clinical features based on specific characteristics of the abnormal protein and the response induced within the parenchymal tissue. Monoclonal immunoglobulin G (IgG) deposition can manifest as a different glomerular disease. Proliferative glomerulonephritis (GN) with monoclonal IgG deposits (PGNMID) is a unique entity mimicking immune complex GN that does not conform to any of those subtypes. IgG monoclonal granular deposition in the glomeruli with a pattern similar to immune complex disease suggested by C3 and C1q deposition should prompt consideration of PGNMID. Literature is scarce in terms of recurrence of disease in renal allografts. In this article we present the clinical-pathologic features of three cases of PGNMID in the renal allograft showing the variable course and manifestation of the disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058641093

Download citation: RISBibTeXText

PMID: 26613031

DOI: 10.1093/ckj/sfv105


Related references

Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin deposits in kidney allografts treated with anti-cd20 antibodies. Transplantation 2019, 2019

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft. Nephrology 21 Suppl 1: 48-52, 2017

Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts. Bmc Nephrology 19(1): 173, 2018

AJKD Atlas of Renal Pathology: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits. American Journal of Kidney Diseases 67(3): E13-E15, 2016

Proliferative glomerulonephritis with monoclonal immunoglobulin A light-chain deposits in the renal allograft. Nephrology 19 Suppl 3: 49-51, 2015

Early recurrence of proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a renal allograft. Saudi Journal of Kidney Diseases and Transplantation 27(2): 381-385, 2016

Proliferative glomerulonephritis with monoclonal immunoglobulin light chain deposits: a rare entity mimicking immune-complex glomerulonephritis. Internal Medicine 51(23): 3273-3276, 2014

Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Nephrology 2018, 2018

Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains. Indian Journal of Nephrology 25(6): 344-348, 2015

Proliferative glomerulonephritis with monoclonal IgG deposits in two kidney allografts successfully treated with rituximab. Clinical Kidney Journal 10(3): 405-410, 2017

Proliferative glomerulonephritis with monoclonal IgG deposits recurs or may develop de novo in kidney allografts. American Journal of Kidney Diseases 58(2): 276-281, 2011

IgA-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. American Journal of Medicine 2019, 2019

Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin ?1 CH2 heavy chain and ? light chain A new variant of monoclonal immunoglobulin deposition disease. 2013

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a kidney allograft. American Journal of Kidney Diseases 63(2): 318-323, 2014

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits of lambda chains. Proceedings 31(2): 187-188, 2018